U.S. Markets closed

Free Research Reports on Boston Scientific and Three More Medical Equipment Stocks

Stock Research Monitor: KOOL, CHFS, and ISRG

LONDON, UK / ACCESSWIRE / June 22, 2018 / If you want a free Stock Review on BSX sign up now at www.wallstequities.com/registration. Today's research coverage on WallStEquities.com is focused on four Medical Appliances and Equipment stocks, particularly, Boston Scientific Corp. (NYSE: BSX), Cesca Therapeutics Inc. (NASDAQ: KOOL), CHF Solutions Inc. (NASDAQ: CHFS), and Intuitive Surgical Inc. (NASDAQ: ISRG). These companies belong to the healthcare sector, which received an "Outperform" rating from Charles Schwab on June 07th, 2018. As per the brokerage firm, positive factors for the sector include increased need for services and strong financials. All you have to do is sign up today for this free limited time offer by clicking the link below.


Boston Scientific

On Thursday, shares in Marlborough, Massachusetts headquartered Boston Scientific Corp. recorded a trading volume of 4.09 million shares. The stock ended the session 0.25% lower at $32.15. The Company's shares have gained 6.21% in the last month, 19.34% over the previous three months, and 15.19% over the past year. The stock is trading 6.35% above its 50-day moving average and 13.88% above its 200-day moving average. Moreover, shares of Boston Scientific, which develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide, have a Relative Strength Index (RSI) of 56.61. Get the full research report on BSX for free by clicking below at:


Cesca Therapeutics

Rancho Cordova, California headquartered Cesca Therapeutics Inc.'s stock closed the day 7.10% lower at $0.47. A total volume of 1.02 million shares was traded, which was above their three months average volume of 711,210 shares. The Company's shares are trading 52.43% below their 50-day moving average. Additionally, shares of Cesca Therapeutics, which develops, commercializes, and markets a range of automated technologies and products for cell-based therapeutics in the US, China, rest of Asia, Europe, and internationally, have an RSI of 30.91.

On May 23rd, 2018, research firm H.C. Wainwright initiated a 'Buy' rating on the Company's stock.

On June 04th, 2018, Cesca Therapeutics announced that it is reducing its US and India workforce by approximately 25%, to a total of 60 full-time equivalent employees, under a plan to be substantially completed by the end of June. This reduction is designed to lower operating expenses while the Company focuses on driving growth of revenue-generating products and, at the same time, continuing to develop and commercialize the CAR-TXpress™ cellular processing platform and related X-Series™ products. Today's complimentary research report on KOOL is accessible at:


CHF Solutions

Shares in Eden Prairie, Minnesota-based CHF Solutions Inc. recorded a trading volume of 54,409 shares. The stock ended yesterday's trading session 1.55% lower at $2.54. The Company's shares are trading below their 50-day moving average by 14.43%. Furthermore, shares of CHF Solutions, which develops cardiac and coronary disease products primarily in the US, have an RSI of 34.52.

On June 06th, 2018, CHF Solutions announced that it will be exhibiting at the 14th Annual American Association of Heart Failure Nurses Meeting from June 28th to 30th, 2018 in Chicago. The Company will be featuring the Aquadex FlexFlow System and highlighting the clinically proven benefits of the therapy. The Company can be found at Booth #313 on the exhibition floor at the Sheraton Grand Chicago throughout the conference. Sign up for free on Wall St. Equities and claim the latest report on CHFS at:


Intuitive Surgical

Sunnyvale, California headquartered Intuitive Surgical Inc.'s stock finished Thursday's session 0.08% lower at $487.08 with a total trading volume of 483,281 shares. The Company's shares have advanced 7.14% in the last month, 17.68% over the previous three months, and 53.29% over the past year. The stock is trading above its 50-day and 200-day moving averages by 5.51% and 19.29%, respectively. Additionally, shares of Intuitive Surgical, which designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories, have an RSI of 60.86.

On May 29th, 2018, Intuitive Surgical announced that it has begun direct operations in India, following seven years of doing business in the country through a distributor, Vattikuti Technologies Pvt. Ltd. In support of the Company's commitment to India, it also named Mandeep Singh Kumar as its general manager. See the free research coverage on ISRG at:


Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.


WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://wallstequities.com/legal-disclaimer/


For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities